Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes

NCT04852029 is registered in ClinicalTrials.gov with Reproductive Medicine Associates of New Jersey as lead sponsor.

NCT NCT04852029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04852029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes
Lead sponsor
Reproductive Medicine Associates of New Jersey
Phase
Not applicable
Overall status
Terminated
Start date
August 16, 2021
Completion date
December 31, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, female